Lei Zhang1, Wei-Hong Zhang, Lian Zhang, Pei-Yu Wang. 1. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.
Abstract
OBJECTIVE: This study aims to estimate the up-to-date prevalence of overweight/obesity in the suburban area of Beijing, China, and its associations with hypertension, diabetes, dyslipidemia, and metabolic syndrome (MetS). METHODS: A cross-sectional survey in 19,003 suburban adults was carried out in Beijing, 2007. Overweight and obesity class 1, 2, and 3 were defined as a body mass index (BMI) of 25.0-29.9, 30.0-34.9, 35.0-39.9, and ≥ 40 kg/m(2), respectively. RESULTS: The age-standardized prevalence of overweight/obesity was 31.9% in the study. With increasing BMI, the prevalence of hypertension, diabetes, dyslipidemia, and MetS also increased. With normal body weight as reference, the adjusted odds ratio (95% confidence interval) of hypertension for overweight and obesity class 1-3 was 2.5 (2.2-2.7), 3.1 (2.8-3.4), 3.6 (3.1-4.3), and 4.5 (4.0-5.2), respectively. The same trend was observed for diabetes and MetS. For dyslipidemia, however, participants with obesity class 2 had the highest odds ratio. CONCLUSION: The prevalence of hypertension, diabetes, dyslipidemia, and MetS increases with increasing BMI. Overweight/obesity is an important risk factor for these diseases. To reduce the social burden of these obesity-related diseases, effective strategies for the prevention of overweight/obesity should be implemented.
OBJECTIVE: This study aims to estimate the up-to-date prevalence of overweight/obesity in the suburban area of Beijing, China, and its associations with hypertension, diabetes, dyslipidemia, and metabolic syndrome (MetS). METHODS: A cross-sectional survey in 19,003 suburban adults was carried out in Beijing, 2007. Overweight and obesity class 1, 2, and 3 were defined as a body mass index (BMI) of 25.0-29.9, 30.0-34.9, 35.0-39.9, and ≥ 40 kg/m(2), respectively. RESULTS: The age-standardized prevalence of overweight/obesity was 31.9% in the study. With increasing BMI, the prevalence of hypertension, diabetes, dyslipidemia, and MetS also increased. With normal body weight as reference, the adjusted odds ratio (95% confidence interval) of hypertension for overweight and obesity class 1-3 was 2.5 (2.2-2.7), 3.1 (2.8-3.4), 3.6 (3.1-4.3), and 4.5 (4.0-5.2), respectively. The same trend was observed for diabetes and MetS. For dyslipidemia, however, participants with obesity class 2 had the highest odds ratio. CONCLUSION: The prevalence of hypertension, diabetes, dyslipidemia, and MetS increases with increasing BMI. Overweight/obesity is an important risk factor for these diseases. To reduce the social burden of these obesity-related diseases, effective strategies for the prevention of overweight/obesity should be implemented.
Authors: Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel Journal: N Engl J Med Date: 2004-12-23 Impact factor: 91.245
Authors: X Q Lao; G Neil Thomas; C Q Jiang; W S Zhang; P Yin; P Adab; T H Lam; K K Cheng Journal: J Endocrinol Invest Date: 2006-12 Impact factor: 4.256
Authors: Y Dong; W Gao; H Nan; H Yu; F Li; W Duan; Y Wang; Bin Sun; R Qian; J Tuomilehto; Q Qiao Journal: Diabet Med Date: 2005-10 Impact factor: 4.359
Authors: Paul Poirier; Thomas D Giles; George A Bray; Yuling Hong; Judith S Stern; F Xavier Pi-Sunyer; Robert H Eckel Journal: Circulation Date: 2005-12-27 Impact factor: 29.690
Authors: F C Howarth; M A Qureshi; Z Hassan; D Isaev; K Parekh; A John; M Oz; H Raza; E Adeghate; T E Adrian Journal: Mol Cell Biochem Date: 2011-10-19 Impact factor: 3.396
Authors: Chuang Yuan; Christopher W K Lai; Lawrence W C Chan; Meyrick Chow; Helen K W Law; Michael Ying Journal: J Diabetes Res Date: 2014-04-22 Impact factor: 4.011